1. Introduction
===============

According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide. Among these, arterial hypertension has a high prevalence and is associated with other conditions, such as myocardial infarction and stroke \[[@B1-molecules-18-05814]\]. Although there are more than 200 drugs that lower blood pressure, less than a third of the hypertension cases are successfully treated due to their low efficacy, detrimental side effects and lack of cardiovascular risk reduction \[[@B2-molecules-18-05814]\]. In addition, the etiology of hypertension has been associated with vascular endothelial dysfunction, which is characterized by an uncoupling between the release of endothelial factors such as nitric oxide (NO), prostacyclin (PGI~2~) and endothelium-derived hyperpolarization (EDH), as well as effects on endothelium-dependent contractile mechanisms, and the associated change in vascular smooth muscle tone \[[@B3-molecules-18-05814]\].

Some studies have suggested that changes in the bioavailability of endothelium-derived NO may be responsible for endothelial dysfunction and the related altered blood pressure and myocardial infarction \[[@B4-molecules-18-05814],[@B5-molecules-18-05814],[@B6-molecules-18-05814],[@B7-molecules-18-05814],[@B8-molecules-18-05814],[@B9-molecules-18-05814],[@B10-molecules-18-05814]\]. Such altered NO levels can be due to dysfunction of soluble guanylate cyclase protein (sGC), with changes in the levels of this protein likely related to the pathophysiology of pulmonary hypertension and hypoxia \[[@B11-molecules-18-05814],[@B12-molecules-18-05814]\]. With regard to vascular smooth muscle relaxation, various cardiovascular diseases, such as coronary vasospasm \[[@B13-molecules-18-05814],[@B14-molecules-18-05814]\], cardiac ischemia \[[@B15-molecules-18-05814]\] and hypertension \[[@B16-molecules-18-05814]\] have also been associated with altered expression and activation of various potassium channels. Based on the above evidence, we are currently seeking new therapeutic strategies for preventing and treating these conditions that also have relaxing effects on vascular smooth muscle.

In this context, plants are a major source of new biologically active compounds, and the ethnomedical knowledge of traditional medicine from around the world is a useful starting point for determining their efficacy. In addition, due to the multifactorial nature of cardiovascular disease such as hypertension, knowledge of the mechanisms of action of each of the compounds proposed for use in the treatment for this disease is a crucial element for planning and developing different therapeutic strategies. Therefore, the present work reviews the previously reported vasodilator compounds isolated from plants and the different mechanisms of action involved in their vasodilator effects.

2. Search Strategy
==================

The literature review focused on the past 22 years (1990 to 2012), taking into account studies on the vasodilating activity of plant-based treatments and the compounds derived from them. We reviewed more than 450 abstracts on this topic. The search was focused on those metabolites with a vasodilator effect whose mechanism of action involved the vascular endothelium and the arterial smooth muscle vasorelaxation pathways; we did not consider the antioxidant activity or reactive oxygen species scavenging.

3. Types of Compounds with Vasodilator Effects
==============================================

We identified 207 vasodilator metabolites together with their possible mechanism(s) of action. First, these compounds were classified according to their chemical nature. It is clear that most compounds with vasodilator activity are alkaloids, flavonoids, or terpenoids ([Figure 1](#molecules-18-05814-f001){ref-type="fig"}). The classification of these compounds offers an overview of the types of compounds that present significant vasodilator activity and of the structural diversity exhibited by these bioactive compounds.

![Classification of vasodilator compounds obtained from plants according to their chemical nature.](molecules-18-05814-g001){#molecules-18-05814-f001}

Some of these compounds have been studied on multiple occasions, and various mechanisms of action have been proposed to explain their vasodilatory activities. These compounds include the flavonoids naringenin \[[@B17-molecules-18-05814],[@B18-molecules-18-05814],[@B19-molecules-18-05814]\], dioclein \[[@B20-molecules-18-05814],[@B21-molecules-18-05814],[@B22-molecules-18-05814],[@B23-molecules-18-05814]\], quercetin \[[@B24-molecules-18-05814],[@B25-molecules-18-05814],[@B26-molecules-18-05814],[@B27-molecules-18-05814],[@B28-molecules-18-05814]\] and (−)-epigallocatechin-3-gallate \[[@B29-molecules-18-05814],[@B30-molecules-18-05814],[@B31-molecules-18-05814]\]; the polyphenols piceatannol \[[@B32-molecules-18-05814],[@B33-molecules-18-05814]\] and resveratrol \[[@B34-molecules-18-05814],[@B35-molecules-18-05814],[@B36-molecules-18-05814]\]; the sesquiterpene polygodial \[[@B37-molecules-18-05814],[@B38-molecules-18-05814],[@B39-molecules-18-05814]\]; the monoterpene rotundifolone \[[@B40-molecules-18-05814],[@B41-molecules-18-05814],[@B42-molecules-18-05814]\] and the alkaloid rutaecarpine \[[@B43-molecules-18-05814],[@B44-molecules-18-05814],[@B45-molecules-18-05814],[@B46-molecules-18-05814]\].

In other cases, mixtures of various compounds obtained from plants or the products generated from them were studied; examples include polyphenols in red wine \[[@B47-molecules-18-05814],[@B48-molecules-18-05814]\], saponins from ginseng \[[@B49-molecules-18-05814]\], proanthocyanidins from persimmon leaf tea \[[@B50-molecules-18-05814]\] and green tea \[[@B48-molecules-18-05814],[@B51-molecules-18-05814]\], as well as the xanthones obtained from *Halenia elliptica* \[[@B52-molecules-18-05814]\]. In 34 plants, two or more vasodilator compounds were identified, which in some cases had different mechanisms of action. Examples of this are the chalcones isolated from *Angelica keiskei* \[[@B53-molecules-18-05814]\], the alkaloids obtained from *Peganum harmala* \[[@B54-molecules-18-05814]\], the glycosides identified in *Melaleuca quinquenervia* \[[@B55-molecules-18-05814]\] and the macrocyclic bis(bibenzyls) from liverworts \[[@B56-molecules-18-05814]\]. In these examples, the fundamental difference between the mechanisms of action proposed for the isolated compounds is based on their dependence or independence on the endothelium, the involvement of the NO/cGMP pathway and the blockage of voltage-dependent Ca^2+^ channels.

4. Proposed Mechanisms of Action
================================

Different mechanisms of action were proposed to explain the vasodilator effect of the 207 compounds derived from plants ([Figure 2](#molecules-18-05814-f002){ref-type="fig"}).

![Classification of compounds obtained from plants according to the main mechanism(s) of action involved in their vasodilator effect.](molecules-18-05814-g002){#molecules-18-05814-f002}

Analysis of the mechanisms of action of these compounds revealed that, on the one hand, the vasodilator effect of a significant number of compounds (40%) involves two or more mechanisms ([Table 1](#molecules-18-05814-t001){ref-type="table"}). On the other hand, as shown in [Figure 2](#molecules-18-05814-f002){ref-type="fig"}, over half of the tested compounds have a mechanism of action that requires the participation of the endothelium, at least in part. Therefore, endothelium-derived factors play a key role in the mechanisms of action of these vasodilators. The mechanisms of action most frequently assessed in the vasodilator effects of the plant compounds were activation of the NO/cGMP pathway, blockade of Ca^2+^ channels, and activation of K^+^ channels.

5. Participation of the Endothelium in the Mechanism of Action
==============================================================

The vascular endothelium synthesizes and releases a broad spectrum of vasoactive substances and plays a fundamental role in the regulation and maintenance of cardiovascular homeostasis \[[@B57-molecules-18-05814]\]. Among the main endothelial-derived factors that relax arterial smooth muscle are NO \[[@B58-molecules-18-05814],[@B59-molecules-18-05814]\], PGI~2~ \[[@B59-molecules-18-05814],[@B60-molecules-18-05814]\] and the EDH mechanism, which is associated with calcium-activated potassium channel activation \[[@B59-molecules-18-05814],[@B61-molecules-18-05814]\]. Approximately one third of the compounds analyzed utilized both endothelium-dependent and endothelium-independent mechanisms ([Table 1](#molecules-18-05814-t001){ref-type="table"}). Moreover, among the compounds that produce their vasodilator effect by an endothelium-dependent mechanism, a high percentage (98.4%) involved the NO/cGMP pathway, whereas the PGI~2~/cAMP pathway was involved in the mechanism used by a low percentage (23%) of the vasodilating compounds ([Table 1](#molecules-18-05814-t001){ref-type="table"}). Among the 130 compounds whose mechanism of action was endothelium-dependent, assays for evaluating the participation of endothelial muscarinic receptors were performed in only 18. Four of these compounds involved the participation of this kind of receptors: diosgenin \[[@B62-molecules-18-05814]\], reticuline \[[@B63-molecules-18-05814]\], rotundifolone \[[@B40-molecules-18-05814]\] and ursolic acid \[[@B64-molecules-18-05814]\].

molecules-18-05814-t001_Table 1

###### 

Mechanisms of action proposed for vasodilator compounds obtained from plants.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                       Compound                                                                                         Type of artery/vein              EC~50~                           Endothelium                      NO/cGMP   PGI~2~/cAMP                      PDE                              PKC   K^+^ Ch                      Ca^2+^~ext~ /Ca^2+^~int~    Ref.
  -------------------- ------------------------------------------------------------------------------------------------ -------------------------------- -------------------------------- -------------------------------- --------- -------------------------------- -------------------------------- ----- ---------------------------- --------------------------- -----------------------------------------------------------
  1                    Allicin                                                                                          rat pulmonary                    0.8 µg/mL ^1^                    d                                \+        x                                                                                                                                \[[@B65-molecules-18-05814]\]

  2                    Allyl isothiocyanate                                                                             rat cerebral                     164 µM ^2^                       d                                x         x                                                                       +IK~Ca~,                     +TRPA1/                     \[[@B66-molecules-18-05814]\]

  +SK~Ca~,                                                                                                                                                                                                                                                                                                                                                            

  +K~IR~                                                                                                                                                                                                                                                                                                                                                              

  3                    Alpha-terpineol                                                                                  rat mesenteric                   NR                                                                \+                                                                                                                                         \[[@B67-molecules-18-05814]\]

  4                    Alpha-zearalanol                                                                                 rat aorta                        NR                               d/i                              \+                                                                                +BK~Ca~,                     -VOCC/                      \[[@B68-molecules-18-05814]\]

  +K~ATP~                                                                                                                                                                                                                                                                                                                                                             

  5                    Alpinetin                                                                                        rat mesenteric                   27.5 µM ^1^                      d/i                              \+        x                                                                 \-                                 -VOCC/\                     \[[@B69-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -IP~3~R,\                   
                                                                                                                                                                                                                                                                                                                                          -RyRs                       

  6                    Alstonisine                                                                                      rat aorta                        NR                               d/i                              \+                                                                                x                            -VOCC,-                     \[[@B70-molecules-18-05814]\]

  ROCC/                                                                                                                                                                                                                                                                                                                                                               

  7                    Amentoflavone                                                                                    rat aorta                        NR                               d                                \+        x                                                                       \+                           -VOCC/                      \[[@B71-molecules-18-05814]\]

  8                    Angelic ester of 2-β-hydroxy-8α-*H*-7(11)-eremophilene-12,8-olide                                rat mesenteric                   4.74 ± 0.1 ^§,2^                                                                                                                                                                 -VOCC~L~/                   \[[@B72-molecules-18-05814]\]

  rat aorta            5.43 ± 0.06 ^§,2^                                                                                                                                                                                                                                                                                                                              

  9                    Angelic ester of 2-β-hydroxy-8β-*H*-7(11)-eremophilene-12,8-olide                                rat mesenteric                   4.11 ± 0.02 ^§,2^                                                 x         x                                                                                                    -VOCC~L~/x                  \[[@B72-molecules-18-05814]\]

  rat aorta            4.92 ± 0.09 ^§,2^                                                                                                                                                                                                                                                                                                                              

  10                   Apigenin                                                                                         rat aorta                        3.7 ± 0.5 µM ^1^                 d/i                              \+\       x                                                                 x     +IK~Ca~, +SK~Ca~             -VOCC,\                     \[[@B73-molecules-18-05814]\]
                                                                                                                                                                                                                           x                                                                                                              -ROCC/x\                    
                                                                                                                                                                                                                                                                                                                                          +TRPV4/                     

  rat aorta            63 µM ^5^                                                                                        i                                \[[@B74-molecules-18-05814]\]                                                                                                                                                                                

  rat mesenteric       NR                                                                                               d                                \[[@B75-molecules-18-05814]\]                                                                                                                                                                                

  11                   Apocynin                                                                                         rat aorta                        780 ± 80 µM ^1^                  d/i                              \+        x                                                                       +K~ATP~                      -VOCC,- ROCC/\              \[[@B76-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -IP~3~R                     

  12                   Astragaloside IV                                                                                 rat aorta                        NR                               d/i                              \+        \+                                                                                                   -VOCC,- ROCC/\              \[[@B77-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -IP~3~R                     

  13                   Backebergine                                                                                     rat aorta                        NR                               d/i                              \+                                                                                x                            -VOCC,- ROCC/               \[[@B78-molecules-18-05814]\]

  14                   Baicalin                                                                                         rat mesenteric                   NR                               i                                \+        \+                                                                \-    +BK~Ca~                      -VOCC/                      \[[@B79-molecules-18-05814]\]

  15                   4-Benzoyl-2-C-β-gluco-pyranosyl-3,5-dihydroxy-6-methylphenyl β-[d]{.smallcaps}-glucopyranoside   rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B55-molecules-18-05814]\]

  16                   Berberine                                                                                        rat mesenteric                   1.48 ± 0.16 µM ^1^               d/i                              \+        x                                                                 x     +BK~Ca,~ +K~v~,              x/-RyRs                     \[[@B80-molecules-18-05814]\]

  +K~IR~                                                                                                                                                                                                                                                                                                                                                              

  17                   Betulinic acid                                                                                   rat aorta                        1.67 µM ^1^                      d                                \+        x                                                                                                                                \[[@B81-molecules-18-05814]\]

  18                   Bilobalide                                                                                       rat aorta                        NR                                                                \+                                                                                x                            -VOCC/                      \[[@B82-molecules-18-05814]\]

  19                   Biochanin A                                                                                      rat aorta                        NR                               i                                                                                                                  +BK~Ca~, +K~ATP~             -VOCC,- ROCC/-              \[[@B83-molecules-18-05814]\]

  20                   Brazilin                                                                                         rat aorta                        183 ± 30 µM ^1^                  d                                \+                                                                                                                                         \[[@B84-molecules-18-05814]\]

  rat aorta            i                                                                                                x                                \[[@B85-molecules-18-05814]\]                                                                                                                                                                                

  rat mesenteric       i                                                                                                x                                \[[@B85-molecules-18-05814]\]                                                                                                                                                                                

  21                   (−)-Borneol                                                                                      rat aorta                        4.63 ± 0.15 ^§,1^                i                                                                                                                  +BK~Ca~, +K~v~,              -VOCC~L~/-                  \[[@B86-molecules-18-05814]\]

  +K~ATP~                                                                                                                                                                                                                                                                                                                                                             

  22                   Butein                                                                                           rat aorta                        7.4 ± 1.6 µM ^1^                 d                                \+        x                                \-                                     x                                                        \[[@B87-molecules-18-05814]\]

  23                   Butylidenephthalide                                                                              rat aorta                        4.20 ± 0.07 ^§,3^                d/i                              \+        x                                                                 \-    x                            -VOCC~L~,\                  \[[@B88-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/-                     

  24                   Cadamine                                                                                         rat aorta                        NR                               d/i                              \+                                                                                x                            -VOCC,- ROCC/               \[[@B89-molecules-18-05814]\]

  25                   Caffeic acid                                                                                     rat aorta                        400 µM ^1^                       d/i                              \+                                                                                x                                                        \[[@B90-molecules-18-05814]\]

  26                   Caffeic acid phenethyl ester                                                                     porcine coronary                 4.99 ± 0.17 ^§,1^                d/i                              \+                                                                                                             -VOCC/                      \[[@B91-molecules-18-05814]\]

  rat aorta            5.15 ± 0.0 ^§,4^                                                                                 d                                \+                               x                                          \[[@B92-molecules-18-05814]\]                                                                                                    

  27                   Calycosin                                                                                        rat aorta                        4.46 ± 0.13 ^§,3^                i                                x         x                                                                                                    -VOCC/x                     \[[@B93-molecules-18-05814]\]

  28                   Capsaicin                                                                                        rat mesenteric                   NR                                                                x                                                                                                                                          \[[@B94-molecules-18-05814]\]

  29                   Cardamonin                                                                                       rat mesenteric\                  9.3 µM ^1^\                      d/i                              \+        x                                                                 \-    +BK~Ca~                      -VOCC/- IP~3~R,-RyRs\       \[[@B69-molecules-18-05814]\]\
                                                                                                                        rat tail                         4.63 ± 0.01 ^§,1^                                                                                                                                                                -VOCC/                      \[[@B95-molecules-18-05814]\]

  30                   Carvacrol                                                                                        rat aorta\                       145.4 ± 6.07 µM ^1^              id                               x         x                                                                 \-    +SK~Ca~, +K~IR~,\            -VOCC/-IP~3~R\              \[[@B96-molecules-18-05814]\]\
                                                                                                                        rat cerebral                                                                                                                                                                         +IK~Ca~                      +TRPV3/                     \[[@B97-molecules-18-05814]\]

  78.8 ± 11.9 µM ^2^                                                                                                                                                                                                                                                                                                                                                  

  4.1 µM                                                                                                                                                                                                                                                                                                                                                              

  31                   Cassiarin A                                                                                      rat mesenteric                   6.4 ± 0.8 µM ^1^                 d/i                              \+        x                                                                       +BK~Ca~                                                  \[[@B98-molecules-18-05814]\]

  32                   Cathafoline                                                                                      rat aorta                        NR                               d/i                              \+                                                                                x                            -ROCC/                      \[[@B70-molecules-18-05814]\]

  33                   Centaureidin                                                                                     rat orta                         16.7 ± 1.9 µM ^5^                i                                                                                                                                                                           \[[@B99-molecules-18-05814]\]

  34                   Chrysin                                                                                          rat orta                         16 ± 4 µM ^1^                    d                                \+                                                                                                                                         \[[@B100-molecules-18-05814],[@B101-molecules-18-05814]\]

  35                   Chrysin glucoside                                                                                rat aorta                        52 µM ^5^                        d/i                              \+                                                                                                                                         \[[@B102-molecules-18-05814]\]

  36                   Cinnamaldehyde                                                                                   rat aorta                        NR                               d/i                              \+        x                                                                       x                            -VOCC/                      \[[@B103-molecules-18-05814]\]

  37                   Ethyl cinnamate                                                                                  rat aorta                        380 ± 40 µM ^1^                  d/i                              \+        \+                                                                                                   -VOCC/                      \[[@B104-molecules-18-05814]\]

  38                   1,8-Cineole                                                                                      rat aorta                        663.2 ± 63.8 µg/mL ^1^           d                                \+        x                                                                       x                                                        \[[@B105-molecules-18-05814]\]

  39                   (+)-*cis*-4\'-*O*-Acetyl-3\'- *O*-angeloylkhellactone                                            rat aorta                        NR                               d/i                              \+        x                                                                       x                            -VOCC/                      \[[@B106-molecules-18-05814]\]

  40                   Citral                                                                                           rat aorta                        NR                               d/i                              \+        x                                                                                                    -ROCC/-                     \[[@B102-molecules-18-05814]\]

  41                   Citronellol                                                                                      rat mesenteric                   0.71 ± 0.11 ^§,1^                i                                                                                                                  x                            -VOCC/- IP~3~R,\            \[[@B107-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -RyRs                       

  42                   Coptisine                                                                                        rat aorta                        4.49 ± 0.48 ^§,5^                d/i                              \+        \+                                                                      +K~V~                        -VOCC,- ROCC/-              \[[@B108-molecules-18-05814]\]

  43                   Cornuside                                                                                        rat aorta                        NR                               d                                \+        x                                                                       x                                                        \[[@B109-molecules-18-05814]\]

  44                   Cryptotanshinone                                                                                 rat coronary                     2.65 ± 0.15 µg/mL 6              i                                x         x                                                                       x                            -VOCC~L~/                   \[[@B110-molecules-18-05814]\]

  45                   Curine                                                                                           rat mesentericrat aorta          4.8 ± 1.9 µM ^5^\                i                                                                                                                                               -VOCC/-\                    \[[@B111-molecules-18-05814]\]\
                                                                                                                                                         7.6 ± 1.6 µM ^1^                                                                                                                                                                 - VOCC~L~/-                 \[[@B112-molecules-18-05814]\]

  46                   Curcumin                                                                                         porcine coronary                 6.28 ± 0.28 µM ^4^               d                                \+        x                                                                                                                                \[[@B113-molecules-18-05814]\]

  47                   Cyclosquamosin B                                                                                 rat aorta                        NR                               i                                                                                                                                               -VOCC/                      \[[@B114-molecules-18-05814]\]

  48                   Daidzein                                                                                         rat basilar                      20 ± 7 µM ^3^\                   ii                               x         x                                                                       \+\                          -VOCC/                      \[[@B115-molecules-18-05814]\]\
                                                                                                                                                         7.4 ± 1.9 µM^6^                                                                                                                                     +BK~Ca~, +K~ATP~                                         \[[@B116-molecules-18-05814]\]

  49                   Daidzin                                                                                          rat basilar                      140 ± 21 µM ^3^                  i                                x         x                                                                       +K~ATP~                      -VOCC/                      \[[@B115-molecules-18-05814]\]

  50                   Danshensu                                                                                        rat coronary                     71.5 ± 11 µg/mL ^6^              i                                                                                                                  \+                           -VOCC~L~/                   \[[@B117-molecules-18-05814]\]

  51                   Dehydroevodiamine                                                                                rat mesenteric                   NR                               d/i                              \+        x                                                                       \+                           -VOCC/                      \[[@B118-molecules-18-05814]\]

  52                   Demethylpiperitol                                                                                rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B119-molecules-18-05814]\]

  53                   Denudatin B                                                                                      rat aorta                        21.2 µg/mL ^2^                   i                                ↑cGMP     x                                                                                                    -VOCC,- ROCC/x              \[[@B120-molecules-18-05814]\]

  54                   14-Deoxy-andrographolide                                                                         rat aorta                        NR                               d /i                             \+        x                                                                       x                            -VOCC,\                     \[[@B121-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  55                   Dictamnine                                                                                       rat aorta                        15 µM ^2^                        i                                                                                                                  x                            -VOCC,- ROCC/               \[[@B122-molecules-18-05814]\]

  56                   Dihydrotanshinone                                                                                rat coronary                     10.39 ± 1.69 µM ^6^              i                                x         x                                                                       x                            -VOCC~L~/                   \[[@B123-molecules-18-05814]\]

  57                   3,7-Dihydroxy-2,4-dimethoxyphenanthrene                                                          rat aorta                        NR                               d/i                              \+                                                                                                                                         \[[@B124-molecules-18-05814]\]

  58                   Dioclein                                                                                         rat aorta                        1.3 ± 3.1 µM ^1^                 d                                \+        x\                               \-                               \-    +K~Ca~, +K~V~                -VOCC/-IP~3~R               \[[@B20-molecules-18-05814]\]
                                                                                                                                                                                                                                     x                                                                                                                                

  rat aorta            350 ± 80 µM ^5^                                                                                  i                                \[[@B21-molecules-18-05814]\]                                                                                                                                                                                

  rat mesenteric       0.3 ± 0.06 µM ^1^                                                                                d/i                              \[[@B22-molecules-18-05814]\]                                                                                                                                                                                

  human saphenous      7.3 ± 3.1 µM ^1^                                                                                 i                                \[[@B23-molecules-18-05814]\]                                                                                                                                                                                

  59                   Diosgenin                                                                                        rat mesenteric                   330 ± 120 µM ^1^                 d                                \+        \+                                                                      +BK~Ca~                                                  \[[@B62-molecules-18-05814]\]

  60                   Echinacoside                                                                                     rat aorta                        NR                               d                                \+        x                                                                                                                                \[[@B125-molecules-18-05814]\]

  61                   Ellagic acid                                                                                     rat aorta                        5.60 ± 0.03 ^§,1^                d/i                              \+        x                                                                       x                            -VOCC~L~/                   \[[@B126-molecules-18-05814]\]

  62                   Emodin                                                                                           rat aorta                        NR                               i                                ↑cGMP                                                                                                                                      \[[@B127-molecules-18-05814]\]

  63                   Ent-18-hydroxy-trachyloban-3-one                                                                 rat aorta                        5.7 ± 0.01 ^§,2^                                                  x                                                                                                              -VOCC~L~/                   \[[@B128-molecules-18-05814]\]

  64                   Ent-8(14), 15-pimaradien-3β-ol                                                                   rat aorta                        4.8 ± 0.1 ^§,1^                  d/i                              \+        x                                                                       x                            -VOCC/x                     \[[@B129-molecules-18-05814]\]

  65                   Epicatechin                                                                                      rat aorta                        4.72 ± 0.07 ^§,1^                d                                \+                                                                                                                                         \[[@B130-molecules-18-05814]\]

  66                   7-Epiclusianone                                                                                  rat aorta                        NR                               d                                \+        x                                                                                                                                \[[@B131-molecules-18-05814]\]

  67                   (−)-Epigallocatechin-3-gallate                                                                   rat aorta                        191.8 ± 13 µM ^5^                i                                                                           \-                                     x\                                                       \[[@B29-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                             +BK~Ca~                                                  

  bovine ophtalmic     6.21 ± 0.06 §,6                                                                                  d                                \+                               \[[@B31-molecules-18-05814]\]                                                                                                                                               

  rat aorta            4.76 ± 0.07 ^§,1^                                                                                d                                \+                               \[[@B130-molecules-18-05814]\]                                                                                                                                              

  68                   Equol (daidzein metabolite)                                                                      rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B132-molecules-18-05814]\]

  69                   Eriodictyol                                                                                      rat aorta                        61.1 ± 2 µM ^5^                  i                                                                                                            x                                  -VOCC/                      \[[@B133-molecules-18-05814]\]

  70                   Erythrodiol                                                                                      rat aorta                        3.38 ± 1.27 µM ^1^               d                                \+        x                                                                                                                                \[[@B134-molecules-18-05814]\]

  71                   Eudesmin                                                                                         rat aorta                        10.69 ± 0.77 µg/mL ^1^           d                                \+        \+                                                                                                                               \[[@B135-molecules-18-05814]\]

  72                   Eugenol                                                                                          rat aorta                                                                                                    x                                                                       x                            \- VOCC,- ROCC/x\           \[[@B136-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          - VOCC,- ROCC/              

  rat aorta            1200 µM ^1^                                                                                      d/i                              \+                               \[[@B137-molecules-18-05814]\]                                                                                                                                              

  rat mesenteric                                                                                                        d/i                              x                                \[[@B138-molecules-18-05814]\]                                                                                                                                              

  73                   Euxanthone                                                                                       rat aorta                        32.5 ± 2.5 µM ^5^                i                                x         x                                                                 \-    x                            -VOCC,- ROCC/\              \[[@B139-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -IP~3~R                     

  74                   Evocarpine                                                                                       rat aorta                        9.8 µM ^2^                                                                                                                                                                       -VOCC/                      \[[@B140-molecules-18-05814]\]

  75                   Evodiamine                                                                                       rat mesenteric                   NR                               d/i                                                                                                                x                            -ROCC/x                     \[[@B141-molecules-18-05814]\]

  76                   Ferulic acid                                                                                     rat aorta                        NR                               i                                x                                                                                                              x/                          \[[@B142-molecules-18-05814]\]

  77                   Floranol                                                                                         rat mesenteric                   19.9 ± 2.4 µM ^1^                d/i                              \+        x                                                                       x                            -VOCC/                      \[[@B143-molecules-18-05814]\]

  rat aorta            i                                                                                                x                                \[[@B144-molecules-18-05814]\]                                                                                                                                                                               

  78                   Formononetin                                                                                     rat aorta                        NR                               d/ i                             \+                                                                                \+                           -VOCC/                      \[[@B145-molecules-18-05814]\]

  79                   Forsythide                                                                                       rat aorta                        NR                               i                                                                                                            x                                  -ROCC/                      \[[@B146-molecules-18-05814]\]

  80                   Fraxinellone                                                                                     rat aorta                        25 µM ^2^                                                                                                                                                                        -VOCC/                      \[[@B122-molecules-18-05814]\]

  81                   Galangin                                                                                         rat aorta                        NR                               d/i                              \+        x                                                                                                    -VOCC/                      \[[@B147-molecules-18-05814]\]

  82                   Geissoschizine methyl ether                                                                      rat aorta                        0.744 µM ^5^                     d/i                              \+                                                                                                             -VOCC/                      \[[@B148-molecules-18-05814]\]

  83                   Genistein                                                                                        rabbit coronary                  NR                               i                                x         x                                                                       x                            -VOCC~L~/                   \[[@B149-molecules-18-05814]\]

  human umbilical      -VOCC/-                                                                                          \[[@B150-molecules-18-05814]\]                                                                                                                                                                                                                

  84                   Gigantol                                                                                         rat aorta                        NR                               d/i                              \+                                                                                                                                         \[[@B124-molecules-18-05814]\]

  85                   Ginsenoside Rg3                                                                                  rat aorta                        NR                               d                                \+                                                                                \+                                                       \[[@B151-molecules-18-05814]\]

  86                   Gomisin A                                                                                        rat aorta                        NR                               d/i                              \+                                                                                                                                         \[[@B152-molecules-18-05814]\]

  87                   Gymnopusin                                                                                       rat aorta                        63 µM ^5^                        i                                x                                                                                 +BK~Ca~, +K~ATP~             -VOCC~L~/                   \[[@B153-molecules-18-05814]\]

  88                   Harmaline                                                                                        rat aorta                        32.8 ± 1.17 µM ^2^               d/i                              \+        \+                               \-                                                                  -VOCC/                      \[[@B154-molecules-18-05814]\]

  89                   Harman                                                                                           rat aorta                        9 µM ^1^                         d/i                              \+        x                                                                       x                            -VOCC~L~,\                  \[[@B155-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  90                   Harmine                                                                                          rat aorta                        3.7 ± 1.2 µM ^5^                 i                                x         x                                \-                                                                  -VOCC/                      \[[@B154-molecules-18-05814]\]

  91                   Hematoxylin                                                                                      rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B156-molecules-18-05814]\]

  92                   Hesperetin                                                                                       rat aorta                        62.8 ± 5.0 µM ^5^                i                                x                                          \-                                     x                            -VOCC,- ROCC/               \[[@B157-molecules-18-05814]\]

  93                   Hirsutine                                                                                        rat aorta                        10.6 µM ^5^                      i                                                                                                                                               -VOCC/                      \[[@B148-molecules-18-05814]\]

  94                   4-Hydroxybenzoic acid                                                                            rat aorta                        1780 µM ^1^                      d                                \+                                                                                x                                                        \[[@B90-molecules-18-05814]\]

  95                   4-Hydroxyderricin                                                                                rat aorta                        NR                               d/i                              \+                                                                                                             -VOCC/                      \[[@B53-molecules-18-05814]\]

  96                   1-Hydroxy-2,3,5-trimethoxyxanthone                                                               rat coronary                     1.67 ± 0.27 µM ^6^               d                                \+        x                                                                 \-    x                            -VOCC~L~/x                  \[[@B130-molecules-18-05814]\]

  97                   Hypogallic acid                                                                                  rat aorta                        620 µM ^1^                       d/ i                             \+                                                                                +K~ATP~                                                  \[[@B90-molecules-18-05814]\]

  98                   Icariin                                                                                          rat aorta                        NR                                                                \+                                                                                                                                         \[[@B158-molecules-18-05814]\]

  canine coronary      d                                                                                                \+                               x                                                                           x                                \[[@B159-molecules-18-05814]\]                                                                  

  99                   Imperatorin                                                                                      rat mesenteric\                                                   i                                                                                                                  +BK~Ca~                      -VOCC,- ROCC/-              \[[@B160-molecules-18-05814]\]
                                                                                                                        mouse aorta                                                                                                                                                                                                                                   

  12.2 ± 2.4 µM ^1^    d                                                                                                \+                               \[[@B161-molecules-18-05814]\]                                                                                                                                                                               

  100                  Isoliquiritigenin                                                                                rat aorta                        7.4 ± 1.6 µM ^1^                 i                                ↑cGMP     x                                                                       x                                                        \[[@B162-molecules-18-05814]\]

  101                  Isoplagiochin B                                                                                  rat aorta                        NR                               i                                                                                                                  \+                           -ROCC/                      \[[@B56-molecules-18-05814]\]

  102                  Isoplagiochin D                                                                                  rat aorta                        NR                               i                                                                                                                  x                            -VOCC,- ROCC/               \[[@B56-molecules-18-05814]\]

  103                  Isopropyl 3-(3,4-dihydroxyphenyl)\                                                               rat mesenteric                   7.41 ± 0.08 ^§,5^                i                                                                                                                  +BK~Ca~                      -VOCC,- ROCC/-              \[[@B123-molecules-18-05814]\]
                       -2-hydroxypropanoate                                                                                                                                                                                                                                                                                                                           

  104                  Isorhamnetin                                                                                     rat mesenteric                   5.89 ± 0.11 ^§,5^                i                                x         x                                                                                                                                \[[@B163-molecules-18-05814]\]

  105                  Isorhynchophylline                                                                               rat aorta                        20--30 µM ^2^                    i                                x                                                                                                              -VOCC~L~/- IP~3~R           \[[@B164-molecules-18-05814]\]

  106                  Iso-S-petasin                                                                                    rat aorta                        NR                               i                                                                                                                                               -VOCC~L~/                   \[[@B165-molecules-18-05814]\]

  107                  Isotirumalin                                                                                     rat aorta                        4.84 ± 0.24 ^ǂ,1^                d                                \+                                                                                                                                         \[[@B166-molecules-18-05814]\]

  108                  Jatrophone                                                                                       rat aorta                        11.0 µM ^5^                      d/i                                                                                                                \+                           -VOCC/-                     \[[@B167-molecules-18-05814]\]

  rat portal vein      13.54 µM 5                                                                                       \-                               \[[@B168-molecules-18-05814]\]                                                                                                                                                                               

  109                  Kaempferol                                                                                       rat aorta\                       580 µM ^1^\                      d/i\                             \+\                                                                                                                                        \[[@B90-molecules-18-05814]\]\
                                                                                                                        rat aorta\                       4.81 ± 0.13 ^§,5^\               d/i\                             +                                                                                                                                          \[[@B163-molecules-18-05814]\]\
                                                                                                                        rat mesenteric\                  5.66 ± 0.06 ^§,5^                d                                                                                                                                                                           \[[@B163-molecules-18-05814]\]\
                                                                                                                        porcine coronary\                                                                                                                                                                                                                             \[[@B169-molecules-18-05814]\]\
                                                                                                                        rat aorta                                                                                                                                                                                                                                     \[[@B170-molecules-18-05814]\]

  110                  Kaurenoic acid                                                                                   rat aorta                        NR                               d/i                              \+        x                                                                       +BK~Ca~, +K~V~               -VOCC/x                     \[[@B171-molecules-18-05814]\]

  111                  Keayanidine B                                                                                    rat aorta                        23.3 ± 1.3 µM ^1^                                                 \+                                                                                                                                         \[[@B172-molecules-18-05814]\]

  112                  Keayanine                                                                                        rat aorta                        27.5 ± 2.4 µM ^1^                                                 \+                                                                                                                                         \[[@B172-molecules-18-05814]\]

  113                  Kolaviron                                                                                        rat mesenteric                   NR                               i                                                                                                                  +BK~Ca~, +K~V~               -VOCC~L~/\                  \[[@B173-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          - IP~3~R                    

  114                  Labdane-302                                                                                      rat mesenteric                   5.4 ± 1.4 µM ^1^                 d/i                              \+        \+                                                                                                   -VOCC~L~/                   \[[@B174-molecules-18-05814]\]

  115                  Labd-8 (17)-en-15-oic acid                                                                       rat aorta                        313.6 µg/mL ^2^                  i                                x                                                                                                                                          \[[@B175-molecules-18-05814]\]

  116                  Lectin (of *Pisum arvense*)                                                                      rat aorta                        58.38 ± 1.87 µg/mL ^1^           d                                \+        x                                                                       x                                                        \[[@B176-molecules-18-05814]\]

  117                  Leonurine                                                                                        rat aorta                        86.4 ± 10.4 µM ^1^                                                                                                                                                               \- VOCC~L~/-                \[[@B177-molecules-18-05814]\]

  118                  Leucocyanidol                                                                                    rat aorta                        2.75 ± 0.15 ^§,5^                d/i                              \+                                                                                                                                         \[[@B178-molecules-18-05814]\]

  119                  Ligustilide                                                                                      rat mesenteric                   3.98 ^§,2^                       i                                x                                                                                 x                            -VOCC,- ROCC/\              \[[@B179-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -RyR                        

  rat aorta            4.39 ± 0.11 ^§,1^                                                                                i                                x                                x                                x         \[[@B180-molecules-18-05814]\]                                                                                                   

  120                  (−)-limacine                                                                                     rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B78-molecules-18-05814]\]

  121                  Luteolin                                                                                         rat aorta                        NR                               i                                x                                                                                 +K~IR~, +K~V~                -VOCC/-                     \[[@B17-molecules-18-05814],[@B181-molecules-18-05814]\]

  122                  Machilin D                                                                                       rat aorta                        17.8 µM                          d                                \+                                                                                                                                         \[[@B182-molecules-18-05814]\]

  123                  Marrubenol                                                                                       rat aorta                        11.8 ± 0.3 µM ^2^                                                                                                                                                                -VOCC~L~/                   \[[@B183-molecules-18-05814]\]

  124                  Marrubiin                                                                                        rat aorta                        NR                               d/i                              \+                                                                                                             -VOCC/                      \[[@B184-molecules-18-05814]\]

  125                  10-Methoxyaffinisine                                                                             rat aorta                        NR                               d/i                              \+                                                                                x                            -VOCC/                      \[[@B70-molecules-18-05814]\]

  126                  Methyl brevifolincarboxylate                                                                     rat aorta                        NR                               i                                                                                                                                               -ROCC/x                     \[[@B185-molecules-18-05814]\]

  127                  Methyleugenol                                                                                    rat mesenteric                   NR                               d/i                              \+                                                                                                                                         \[[@B67-molecules-18-05814]\]

  128                  Methylpaeoniflorin                                                                               rat aorta                        10.1 µM ^1^                      d                                \+                                                                                                                                         \[[@B186-molecules-18-05814]\]

  129                  Milonine                                                                                         rat mesenteric                   1.1 µM ^1^                       d/i                              \+        x                                                                       +BK~Ca~, +SK~Ca~,~+~K~ATP~   \- VOCC,- ROCC/\            \[[@B187-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -IP~3~R,-RyR                

  130                  Mollic acid glucoside                                                                            rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B188-molecules-18-05814]\]

  131                  Morolic acid                                                                                     rat aorta                        94.19 µM ^5^                     d                                \+        x                                                                                                                                \[[@B189-molecules-18-05814]\]

  132                  Moronic acid                                                                                     rat aorta                        16.11 µM ^5^                     d                                \+        x                                                                                                                                \[[@B189-molecules-18-05814]\]

  133                  (+)-Nantenine                                                                                    rat aorta                        NR                               i                                                                                                                  x                            -VOCC/x                     \[[@B190-molecules-18-05814]\]

  134                  (+/−)-Naringenin                                                                                 rat aortarat aortarat aorta      71.2 ± 5.3 µM ^1^\               i\                                                                          \-                               \-    +BK~Ca~                      -VDCC,\                     \[[@B17-molecules-18-05814]\]\
                                                                                                                                                         4.68 µM ^5^                      i\                                                                                                                                              -ROCC/                      \[[@B18-molecules-18-05814]\]\
                                                                                                                                                                                          i                                                                                                                                                                           \[[@B19-molecules-18-05814]\]

  135                  Naucline                                                                                         rat aorta                        20 µM ^1^                        i                                                                                                                  x                            -VOCC,\                     \[[@B89-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  136                  1-Nitro-2-phenylethane                                                                           rat aorta                        231.5 µM ^1^                     i                                \+        x                                                                       +K~ATP~, +K~V~                                           \[[@B191-molecules-18-05814]\]

  137                  Norathyriol                                                                                      rat aorta                        NR                               i                                x         x                                                                                                    -VOCC,\                     \[[@B192-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  138                  Oleanolic acid                                                                                   rat aorta                        5.58 ± 1.28 µM ^1^               d                                \+        x                                                                                                                                \[[@B134-molecules-18-05814]\]

  139                  12-*O*-Methylcurine                                                                              rat aorta                        63.2 ± 8.8 µM ^1^                i                                                                                                            \-                                 -VOCC,- ROCC/\              \[[@B193-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -IP~3~R                     

  140                  Orientin                                                                                         New Zealand rabbit aorta         2.28 µM ^1^                      d/i                              \+        x                                                                       x                            \- VOCC,- ROCC/-            \[[@B194-molecules-18-05814]\]

  141                  Osthole                                                                                          rat aorta                        NR                               i                                ↑cGMP     x                                                                                                    \- VOCC,- ROCC/-            \[[@B195-molecules-18-05814]\]

  142                  Paeoniflorin                                                                                     rat aorta                        19.4 µM ^1^                      d                                \+                                                                                                                                         \[[@B186-molecules-18-05814]\]

  143                  Paeonidanin                                                                                      rat aorta                        7.9 µM ^1^                       d                                \+                                                                                                                                         \[[@B186-molecules-18-05814]\]

  144                  Pecrassipine A                                                                                   rat aorta                        NR                               d/i                              \+                                                                                x                            \- VOCC,- ROCC/             \[[@B78-molecules-18-05814]\]

  145                  1,2,3,4,6-Penta-*O*-galloyl-β-[d]{.smallcaps}-glucose                                            rat aorta                        3.6 µM ^1^                       d                                \+        \+                                                                      x                                                        \[[@B196-molecules-18-05814]\]

  146                  Perrottetin                                                                                      rat aorta                        NR                               i                                                                                                                  x                            \- VOCC,- ROCC/             \[[@B56-molecules-18-05814]\]

  147                  Phlomeoic acid                                                                                   rat aorta                        NR                               d/i                              \+                                                                                                             -VOCC/                      \[[@B184-molecules-18-05814]\]

  148                  Phloretin                                                                                        rabbit coronary                  NR                               i                                                                                                                                                                           \[[@B149-molecules-18-05814]\]

  149                  Piceatannol                                                                                      rat aorta                        2.4 ± 0.4 µM 1                   d                                \+        x                                                                       +BK~Ca~                                                  \[[@B32-molecules-18-05814]\]

  rat aorta            d                                                                                                \+                               \[[@B33-molecules-18-05814]\]                                                                                                                                                                                

  150                  Pimaradienoic acid                                                                               rat aorta                        NR                               i                                \+        \+                                                                      x                            -VOCC/x                     \[[@B197-molecules-18-05814]\]

  151                  Pinocembrin                                                                                      rat aorta                        4.37 ± 0.02 ^§,5^                d/i                              \+        x                                                                       +K~ATP~, +K~V~               \- VOCC/- IP~3~R            \[[@B198-molecules-18-05814]\]

  152                  Piperitol (sesamin metabolite)                                                                   rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B119-molecules-18-05814]\]

  153                  Plagiochin A                                                                                     rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B56-molecules-18-05814]\]

  154                  Polygodial                                                                                       rabbit pulmonary                 NR                               d                                \+        x                                                                       x                                                        \[[@B37-molecules-18-05814]\]

  rat portal           \-                                                                                               -VOCC/                           \[[@B38-molecules-18-05814]\]                                                                                                                                                                                

  155                  Pomolic acid                                                                                     rat aorta                        2.45 μM ^5^                      d                                \+        x                                                                       +K~ATP~                                                  \[[@B199-molecules-18-05814]\]

  156                  (+) Praeruptorin A                                                                               rat aorta                        35.4 ± 3.6 µM ^1^                d                                \+                                                                                x                            \- VOCC,- ROCC/\            \[[@B200-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -IP~3~R                     

  157                  (−) Praeruptorin A                                                                               rat aorta                        45.8 ± 2.5 µM ^1^                i                                x                                                                                 x                            -VOCC,\                     \[[@B200-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/\                     
                                                                                                                                                                                                                                                                                                                                          -IP~3~R                     

  158                  Proanthocyanidins\*                                                                              rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B50-molecules-18-05814]\]

  159                  Procyanidins\*                                                                                   human internal mammary           NR                               d                                \+        \+                                                                      +K~ATP~, +SK~Ca~,\                                       \[[@B201-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                             +K~V~, +K~IR~                                            

  rat aorta            d                                                                                                \+                                                                \[[@B202-molecules-18-05814]\]                                                                                                                                              

  porcine coronary     \+                                                                                               \+                                                                \[[@B203-molecules-18-05814]\]                                                                                                                                              

  160                  Protosappanin D                                                                                  rat aortarat mesenteric          NR                               d/i                              \+        \+                                                                                                                               \[[@B85-molecules-18-05814]\]

  161                  Puerarin                                                                                         rat basilar                      304 ± 49 µM ^3^                  d/i                              \+        x                                                                       \+                           x/                          \[[@B115-molecules-18-05814]\]

  162                  Quercetin                                                                                        rat aorta                        NR                               i                                x\        \+\                              x                                \-    +BK~Ca~                                                  \[[@B24-molecules-18-05814]\]
                                                                                                                                                                                                                           +\        x                                                                                                                                
                                                                                                                                                                                                                           +\                                                                                                                                         
                                                                                                                                                                                                                           x                                                                                                                                          

  rat coronary         3 mM 7                                                                                           d/i                              \[[@B25-molecules-18-05814]\]                                                                                                                                                                                

  pig coronary         NR                                                                                               i                                \[[@B27-molecules-18-05814]\]                                                                                                                                                                                

  rat aorta            4.68 ± 0.08 ^§,5^                                                                                i                                \[[@B163-molecules-18-05814]\]                                                                                                                                                                               

  rat mesenteric       5.35 ± 0.15 ^§,5^                                                                                i                                \[[@B163-molecules-18-05814]\]                                                                                                                                                                               

  rat aorta            4.36 ± 0.05 ^§,1^                                                                                d                                \[[@B204-molecules-18-05814]\]                                                                                                                                                                               

  rat portal           59.5 ± 11.1 µM ^4^                                                                               i                                \[[@B205-molecules-18-05814]\]                                                                                                                                                                               

  163                  Quercetin 3,7-dimethyl ether                                                                     rat aorta                        4.70 ± 0.18 ^§,1^                d                                \+                                                                                                                                         \[[@B206-molecules-18-05814]\]

  164                  Quercetine-3-*O*-galactoside                                                                     rat basilar                      20.4 ± 4.49 µM ^3^               d/i                              \+        \+                                                                      \+                                                       \[[@B207-molecules-18-05814]\]

  165                  Resveratrol                                                                                      rat aorta                        4.52 ± 0.11 ^§,1^\               i                                \+                                                                                +K~V~\                       -VOCC/                      \[[@B35-molecules-18-05814]\]
                                                                                                                                                         4.99 ± 0.11 ^§,1^                                                                                                                                   +K~V~                                                    

  rat aorta            d/i                                                                                              \[[@B208-molecules-18-05814]\]                                                                                                                                                                                                                

  rat mesenteric       d/i                                                                                              \[[@B209-molecules-18-05814]\]                                                                                                                                                                                                                

  166                  Reticuline                                                                                       rat aortarat aorta               40 ± 10 µM ^1^\                  d/i                              \+        x                                                                                                    \- VOCC~L~/- IP~3~R\        \[[@B63-molecules-18-05814]\]\
                                                                                                                                                         NR                                                                                                                                                                               -VOCC~L~/                   \[[@B210-molecules-18-05814]\]

  167                  Rhynchophylline                                                                                  rat aorta                        20--30 µM ^2^                    i                                x                                                                                                              \- VOCC~L~/- IP~3~R,- RyR   \[[@B164-molecules-18-05814]\]

  168                  Riccardin A                                                                                      rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B56-molecules-18-05814]\]

  169                  Riccardin C                                                                                      rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B56-molecules-18-05814]\]

  170                  Riccardin F                                                                                      rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B56-molecules-18-05814]\]

  171                  Roseoside                                                                                        rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B55-molecules-18-05814]\]

  172                  Rotundifolone                                                                                    rat aorta                        184 ± 6 µg/mL ^1^                d/i                              \+        \+                                                                      +BK~Ca~                      \- VOCC~L~/- IP~3~R\        \[[@B40-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -VOCC~L~/                   

  rat aorta            NR                                                                                               i                                \[[@B41-molecules-18-05814]\]                                                                                                                                                                                

  rat mesenteric       4.0 ± 0.02 ^§,1^                                                                                 d/i                              \[[@B42-molecules-18-05814]\]                                                                                                                                                                                

  173                  Rutaecarpine                                                                                     rat aorta                        NR                               d                                \+                                                                                x                            -/-\                        \[[@B43-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          - VOCC~L~/- IP~3~R          

  rat aorta            d                                                                                                \+                               \[[@B44-molecules-18-05814]\]                                                                                                                                                                                

  rat aorta                                                                                                                                              \[[@B45-molecules-18-05814]\]                                                                                                                                                                                

  174                  Rutin                                                                                            rat mesenteric rat aorta         NR                               d                                \+        \+                                                                      +K~ATP~                                                  \[[@B211-molecules-18-05814]\]

  175                  Salvianolic acid B                                                                               rat coronary                     147.9 ± 17.4 µg/mL ^6^           i                                                                                                                  \+                           -VOCC/                      \[[@B212-molecules-18-05814]\]

  176                  Sanguinarine                                                                                     rat aorta                        3.18 ± 0.37 µM ^1^               i                                                                                                                                               -VOCC,\                     \[[@B213-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/\                     
                                                                                                                                                                                                                                                                                                                                          -IP~3~R                     

  177                  Saponins from Ginseng\*                                                                                                           NR                                                                                                                                                                               -ROCC/                      \[[@B49-molecules-18-05814]\]

  178                  Sappanchalcone                                                                                   rat aortarat mesenteric          NR                               d                                \+        \+                                                                                                                               \[[@B85-molecules-18-05814]\]

  179                  Saucerneol                                                                                       rat aorta                        2.2 µM                           d                                \+                                                                                                                                         \[[@B182-molecules-18-05814]\]

  180                  Saucerneol D                                                                                     rat aorta                        12.7 µM                          d                                \+                                                                                                                                         \[[@B182-molecules-18-05814]\]

  181                  Scirpusin B                                                                                      rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B214-molecules-18-05814]\]

  182                  Scutellarin                                                                                      rat aorta                        7.7 ± 0.6 µM ^5^                 i                                x         x                                                                 x     x                            -VOCC/x                     \[[@B215-molecules-18-05814]\]

  183                  Senkyunolide A                                                                                   rat aorta                        4.32 ± 0.10 §,^1^                i                                x         x                                                                       x                                                        \[[@B180-molecules-18-05814]\]

  184                  S-petasin                                                                                        rat mesenteric                   6.01 ± 0.08 ^§,3^                i\                               x\        x\                                                                                                   \- VOCC~L~/\                \[[@B72-molecules-18-05814]\]
                                                                                                                                                                                          i                                x         x                                                                                                    - VOCC~L~/                  

  rat aorta            4.76 ± 0.16 ^§,3^                                                                                \[[@B72-molecules-18-05814]\]                                                                                                                                                                                                                 

  rat aorta            6.6 ± 1.4 µM ^2^                                                                                 \[[@B216-molecules-18-05814]\]                                                                                                                                                                                                                

  185                  Tetramethylpyrazine                                                                              rat aorta                        NR                               d/i                              \+\                                                                               +K~ATP~, +SK~Ca~             -VOCC/                      \[[@B217-molecules-18-05814]\]
                                                                                                                                                                                                                           +                                                                                                                                          

  rabbit basilar       NR                                                                                               \[[@B218-molecules-18-05814]\]                                                                                                                                                                                                                

  rat aorta            NR                                                                                               \[[@B219-molecules-18-05814]\]                                                                                                                                                                                                                

  rat pulmonary        522 µM ^1^                                                                                       \[[@B220-molecules-18-05814]\]                                                                                                                                                                                                                

  186                  Tetrandrine                                                                                                                       NR                                                                                                                                                                               -VOCCL/                     \[[@B217-molecules-18-05814]\]

  187                  Thaligrisine                                                                                     rat aorta                        23.0 ± 0.39 µM ^5^                                                                                                                                                               -VOCC/                      \[[@B221-molecules-18-05814]\]

  188                  Thymol                                                                                           rat aorta                        106.4 ± 11.3 µM ^1^              i                                x                                                                           \-                                 -VOCC/-IP3R                 \[[@B96-molecules-18-05814]\]

  189                  Tilianin                                                                                         rat aorta                        240 µM ^5^                       d/i                              \+        x                                                                       \+ K~V~                                                  \[[@B222-molecules-18-05814]\]

  190                  Trans-dehydrocrotonin                                                                            rat aorta                        NR                               d                                \+                                                                                                                                         \[[@B223-molecules-18-05814]\]

  191                  Trans-resveratrol                                                                                rat aorta                        3.12 ± 0.26 µM ^1^               d                                \+                                                                                                                                         \[[@B224-molecules-18-05814],[@B225-molecules-18-05814]\]

  192                  Ursolic acid                                                                                     rat aorta                        44.1 ± 6.1 µM ^5^                d                                \+        x                                                                                                                                \[[@B64-molecules-18-05814]\]

  193                  Villocarine A                                                                                    rat aorta                        NR                               d/i                              \+                                                                                \+                           -VOCC,\                     \[[@B226-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  194                  Vincamedine                                                                                      rat aorta                        NR                               d/i                              \+                                                                                x                            -VOCC,\                     \[[@B227-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  195                  Visnadine                                                                                        rat aortarat portal              NR                                                                                                                                            \-                                 -VOCC~L~/                   \[[@B228-molecules-18-05814]\]

  196                  Visnagin                                                                                         rat aorta                        22 ± 4 µM 5                      i                                                                                                            \-                                 -VOCC~L~,\                  \[[@B229-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  -IP~3~R,-RyR                                                                                                                                                                                                                                                                                                                                                        

  197                  Vitisin C                                                                                        rabbit aorta                     NR                               d                                \+                                                                                                                                         \[[@B230-molecules-18-05814]\]

  198                  Vulgarenol                                                                                       guinea pig heart                 NR                               d                                \+                                                                                                                                         \[[@B231-molecules-18-05814]\]

  199                  Wine polyphenolic compounds \*                                                                   rat aorta                        3.27 ± 0.02 ^§,5^                d                                \+                                                                          x     \+                                                       \[[@B47-molecules-18-05814],[@B178-molecules-18-05814]\]

  200                  Xanthoangelol                                                                                    rat aorta                        NR                               d                                \+                                                                                                             -VOCC/                      \[[@B53-molecules-18-05814]\]

  201                  Xanthoangelol B                                                                                  rat aorta                        NR                               i                                x                                                                                                              -VOCC/                      \[[@B53-molecules-18-05814]\]

  202                  Xanthoangelol E                                                                                  rat aorta                        NR                               d                                \+                                                                                                             -VOCC/                      \[[@B53-molecules-18-05814]\]

  203                  Xanthoangelol F                                                                                  rat aorta                        NR                               d                                \+                                                                                                             -VOCC/                      \[[@B53-molecules-18-05814]\]

  204                  Xanthone                                                                                         rat aorta                        60.26 ± 8.43 µM 5                i                                          ↑cAMP                                                                                                -VOCC,\                     \[[@B232-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/x                     

  205                  Xanthorrhizol                                                                                    rat aorta                        NR                               i                                x         x                                                                                                    -VOCC,\                     \[[@B233-molecules-18-05814]\]
                                                                                                                                                                                                                                                                                                                                          -ROCC/                      

  206                  Zearalanone                                                                                      rabbit coronary                  NR                               i                                                                                                                                               -VOCC/                      \[[@B149-molecules-18-05814]\]

  207                  (*Z*)-3-methylthioacrylic ester of 2beta-hydroxy-8betaH-7(11)-eremophilene-12,8-olide            rat mesentericrat aorta          5.24 ± 0.13 ^§,3^\               i                                x         x                                                                                                    -VOCC~L~/                   \[[@B72-molecules-18-05814]\]
                                                                                                                                                         4.26 ± 0.17 ^§,3^                                                                                                                                                                                            
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Abbreviations:* d, endothelium-dependent; i, endothelium-independent; +, activation; -, inactivation; x, without involvement; EC~50~, median effective concentration; NO/cGMP, NO/cGMP pathway; PGI~2~/cAMP, PGI~2~/cAMP pathway; PDE, phosphodiesterase; PKC, protein kinase C; Ca^2+^~ext~, extracellular Ca^2+^ influx; Ca^2+^~int~, Ca^2+^ release from intracellular stores; ↑cGMP, increased levels of cGMP; ↑cAMP, increased levels of cAMP; BK~Ca~, high-conductance Ca^2+^ activated K^+^ channels; IK~Ca~, intermediate-conductance Ca^2+^-activated K^+^ channels; SK~Ca~, low-conductance Ca^2+^-activated K^+^ channels; K~ATP~, ATP-dependent K^+^ channels; K~IR~, inwardly rectifying K^+^ channels; K~V~, voltage-dependent K^+^ channels; VOCC, voltage-operated Ca^2+^ channels, VOCC~L~, L-type voltage-operated Ca^2+^ channels; ROCC, receptor-operated Ca^2+^ channels; IP~3~R, inositol triphosphate receptor; RyR, caffeine/ryanodine receptor. EC~50~ determined in tissues precontracted with ^1^ phenylephrine, ^2^ KCl, ^3^ U46619, ^4^ prostaglandin F2α, ^5^ norepinephrine, ^6^ 5-hydroxytryptamine, ^7^ 4-aminopyridine. § pD2 (−log EC~50~); ǂ pIC30 (−log IC~30~). NR, not reported; No symbol, not investigated; \* Mixtures of compounds obtained from a single plant species.

6. Compounds Acting on the NO/cGMP Pathway
==========================================

Although three distinct isoforms of NO synthase (NOS) have been identified (endothelial, eNOS; inducible, iNOS; and neuronal, nNOS), it has generally been accepted that regulation of vascular tone is primarily dependent upon the release of NO from eNOS \[[@B234-molecules-18-05814]\]. However, some studies have suggested that nNOS \[[@B235-molecules-18-05814]\] and iNOS \[[@B236-molecules-18-05814]\] may also be involved in this process. Therefore, NO synthesis can be modulated by regulating the activity or gene expression of the three NOS isoforms \[[@B237-molecules-18-05814]\]. NO, produced by these enzymes, dilates all types of blood vessels by stimulating sGC and increasing cGMP in smooth muscle cells \[[@B238-molecules-18-05814]\].

6.1. Compounds that Regulate eNOS Expression
--------------------------------------------

Although eNOS was initially characterized as a constitutive enzyme of the vascular endothelium, there is evidence to suggest that the expression of this enzyme can be regulated by physiological stimuli or by the actions of certain compounds \[[@B239-molecules-18-05814],[@B240-molecules-18-05814]\]. Some of the compounds obtained from plants that regulate the gene expression of eNOS are betulinic acid, a pentacyclic triterpene isolated from *Zizyphi spinosi*, a plant used in traditional Chinese medicine for the treatment of cardiovascular diseases \[[@B241-molecules-18-05814]\]; several flavonoids, such as cynaroside and luteolin, which are constituents of the plants *Cynara scolymus* L. (artichoke) and *Prunella vulgaris* \[[@B242-molecules-18-05814],[@B243-molecules-18-05814]\]; alkaloids, such as keayanidine B and keayanine, isolated from *Microdesmis keayana*, an African tropical plant whose roots are used in traditional medicine for treating erectile dysfunction \[[@B172-molecules-18-05814]\]; and other metabolites, such as piceatannol \[[@B244-molecules-18-05814]\].

In general, assays for determining the contributions of these compounds to the regulation of eNOS gene expression have been performed on endothelial cells from the human umbilical cord vein (the EA. hy926 cell line) \[[@B244-molecules-18-05814]\]. For example, in the study of icariin, a flavonoid isolated from *Epimedii herba*, this cell line was cultured in the presence of different concentrations of it. Subsequently, reverse transcriptase PCR and western blot techniques were used to determine the change in the levels of mRNA and protein of eNOS, respectively. The results indicated that after incubation for 12 h in the presence of icariin, both the mRNA expression and the protein levels of eNOS increased significantly as a function of time and concentration. Additionally, icariin induced a significant relaxation on rat aorta and canine coronary artery \[[@B158-molecules-18-05814],[@B159-molecules-18-05814]\].

6.2. Compounds that Regulate eNOS Activity
------------------------------------------

In general, assessment of the participation of the NO/cGMP pathway is accomplished through the use of inhibitors of eNOS and sGC. In the case of eNOS, the most commonly inhibitor used is N~ω~-nitro-L-arginine methyl ester (L-NAME) or some other derivatives, such as N^G^-monomethyl-L-arginine (L-NMMA) \[[@B82-molecules-18-05814],[@B162-molecules-18-05814]\]. In the case of sGC, 1*H*-\[[@B1-molecules-18-05814],[@B2-molecules-18-05814],[@B4-molecules-18-05814]\]oxadiazole\[4,3-a\]quinoxaline-1-one (ODQ) or methylene blue \[[@B125-molecules-18-05814]\] are the most commonly used inhibitors.

The tissues commonly used to test the effects of compounds on the NO/cGMP pathway are isolated rat thoracic aorta rings or arteries from the mesenteric artery bed \[[@B126-molecules-18-05814],[@B187-molecules-18-05814]\]. However, other tissues have been used, such as rat basilar artery \[[@B115-molecules-18-05814]\], rabbit thoracic aorta \[[@B230-molecules-18-05814]\], porcine coronary artery \[[@B113-molecules-18-05814]\], canine coronary artery \[[@B159-molecules-18-05814]\], and bovine ophthalmic artery \[[@B31-molecules-18-05814]\]. An example of a study where both models, the isolated aorta and the mesenteric artery bed, were employed comprises evaluation of the vasodilator effect of alpha-terpineol and methyl eugenol, which were obtained from the essential oil of *Croton nepetaefolius*. It was found that the NO/cGMP pathway was involved in the vasodilatory activity of these compounds, as the pathway was inhibited in the presence of L-NAME and methylene blue \[[@B67-molecules-18-05814]\].

An example of a compound whose mechanism of action involves activation of eNOS is brazilin, a homoisoflavonoid obtained from *Caesalpinia sappan L*. This metabolite induced an increase in cGMP levels and vasodilation of the aorta in a concentration-dependent manner. The effect of brazilin has also been studied in cultured endothelial cells from the umbilical cord vein. In these cell cultures, brazilin induced a concentration-dependent increase in eNOS activity by causing an elevation of intracellular Ca^2+^ in endothelial cells, thus stimulating calmodulin, which in turn activated eNOS \[[@B84-molecules-18-05814]\]. A similar mechanism of action was proposed for gomisin A, a lignane obtained from *Schisandra chinensis;* however, in this case, human coronary endothelial cells were used to determine the activation of eNOS \[[@B245-molecules-18-05814]\].

Mechanisms that activate eNOS through the phosphatidylinositol-3-kinase/protein kinase B (PIK3/Akt) pathway have also been proposed. The vasodilator effect of epigallocatechin-3-gallate, the most abundant catechin in tea (*Camellia sinensis*), was dramatically reduced by the PIK3 inhibitor wortmannin and the Akt inhibitor SH6, suggesting that this compound activates the NO/cGMP pathway by inducing the phosphorylation of eNOS \[[@B31-molecules-18-05814]\]. Moreover, this mechanism has also been suggested to account for the vasodilatory activity of proanthocyanidins from the persimmon leaf, quercetin and resveratrol. The effect of these metabolites was studied in diverse cultured endothelial cells and results have pointed out that these compounds induced vasorelaxation through the endothelium-dependent NO/cGMP pathway via sequential phosphorylation of Akt \[[@B28-molecules-18-05814],[@B36-molecules-18-05814],[@B50-molecules-18-05814]\].

6.3. Compounds that Regulate the Activity and Expression of sGC
---------------------------------------------------------------

The results of some studies have suggested that the vasodilator effects of certain compounds produced from plants are mediated by the activation of sGC and, therefore, by an increase in cGMP levels. The levels of sGC have been quantified on rings of isolated rat aortas using immunological techniques \[[@B45-molecules-18-05814],[@B162-molecules-18-05814]\]. In this context, it has been proposed that isoliquiritigenin, a chalcone isolated from *Dalbergia odorifera*, relaxes the aorta by an endothelium-independent mechanism. Furthermore, incubation of the aorta with this chalcone caused an increase in cGMP levels and a slight increase in cAMP \[[@B162-molecules-18-05814]\]. It has also been proposed that the metabolites emodin and osthole produce their vasodilator effects through a mechanism of action involving increased levels of sGC \[[@B127-molecules-18-05814],[@B195-molecules-18-05814]\].

About 40% of the compounds showed more than one mechanism of action ([Table 1](#molecules-18-05814-t001){ref-type="table"}). For example, alpinetin and cardamonin exert their relaxing effects through both endothelium-dependent and endothelium-independent mechanisms, the former by activation of the NO/cGMP pathway and the latter through the non-selective inhibition of Ca^2+^ channels in smooth muscle cells and the inhibition of the contractile mechanism dependent on protein kinase C (PKC) \[[@B69-molecules-18-05814]\]. Similar mechanisms have been proposed for citral and formononetin; both compounds induced relaxation in rat aortic rings through an endothelium-dependent manner via the nitric oxide pathway, and also involving endothelium-independent vasodilatation by the blockade of Ca^2+^ channels \[[@B102-molecules-18-05814],[@B145-molecules-18-05814]\].

It has also been suggested that the involvement of different mechanisms could depend on the concentration of the metabolite. Low concentrations of caffeic acid phenylethyl ester (CAPE), one of the main components of propolis, induce a relaxing effect on vascular smooth muscle through the activation of the NO/cGMP pathway. In contrast, high concentrations of this compound induce vasodilation in an endothelium-independent manner, likely due to the inhibition of Ca^2+^ entry into the cytoplasm of muscle cells or due to the inhibition of the release of this cation from intracellular stores \[[@B91-molecules-18-05814]\].

Moreover, the mechanism of action depends on the type of vascular bed and species variations. In this sense it has been demonstrated that vascular relaxation attributable to NO is most prominent in large vessels such as the aorta, while in resistance vessels that regulate blood pressure more directly, NO's effects are less evident \[[@B246-molecules-18-05814]\]. As an example of the influence of species variations on the action of compounds that affect NO expression, it was shown that resveratrol induced down-regulation of eNOS gene expression in human endothelial cells \[[@B247-molecules-18-05814]\], in contrast, this compound increased eNOS protein expression in bovine endothelial cells \[[@B248-molecules-18-05814]\]. On the other hand, imperatorin, a coumarin obtained from *Angelica dahurica* var. formosana, induced an endothelium-independent relaxation in rat mesenteric arterial rings by blocking the voltage-dependent calcium channel and the receptor-mediated Ca^2+^ influx and Ca^2+^ release \[[@B160-molecules-18-05814]\]. However, in mouse thoracic aorta this coumarin elicited vasodilatation via an endothelium-dependent mechanism involving the nitric oxide pathway \[[@B161-molecules-18-05814]\].

Some studies have conducted *in vivo* assays in addition to tests on isolated tissues. Chrysin glucoside, isolated from the leaves and flowers of *Calycotome villosa*, has been observed to have an endothelium-dependent vasodilator effect on isolated rat aortas and a hypotensive effect when administered intravenously to rats \[[@B249-molecules-18-05814]\]. The results of the *in vivo* assays suggest that the hypotensive effect is probably due to increased vascular relaxation \[[@B22-molecules-18-05814],[@B63-molecules-18-05814],[@B76-molecules-18-05814],[@B107-molecules-18-05814],[@B119-molecules-18-05814],[@B136-molecules-18-05814],[@B165-molecules-18-05814]\].

7. Compounds that Activate the PGI2/cAMP Pathway
================================================

Few studies have proposed the activation of the PGI~2~/cAMP pathway as a mechanism for the vasodilator effects of plant-derived compounds. PGI~2~ is an endogenous vasoactive eicosanoid produced by cyclooxygenase (COX) from arachidonic acid in endothelial cells; its production is stimulated by endogenous agonists such as serotonine, histamine, bradykinin and acetylcholine. In addition to inhibiting platelet aggregation, PGI~2~ also causes relaxation of vascular smooth muscle through stimulation of a G-protein-coupled receptor that, in turn, activates adenylyl cyclase (AC) and thus raises cAMP levels, inducing vasodilation as a result \[[@B250-molecules-18-05814]\]. The participation of this pathway is determined by using indomethacin as an inhibitor of the COX enzyme \[[@B82-molecules-18-05814],[@B154-molecules-18-05814]\]. Some compounds whose mechanism of action involves the activation of this pathway at the level of the endothelium are ethyl cinnamate, isolated from the rhizomes of *Kaempferia galanga* \[[@B104-molecules-18-05814]\]; eudesmin, a lignan obtained from *Piper truncatum* \[[@B135-molecules-18-05814]\]; labdane-302, a diterpene obtained from *Xylopia langsdorffiana* \[[@B174-molecules-18-05814]\]; rutin \[[@B211-molecules-18-05814]\]; and procyanidins, derived from grape seeds \[[@B201-molecules-18-05814]\].

The vasodilator activity of procyanidins was evaluated in human internal mammary aortic rings. It was determined that both the NO/cGMP and the PGI~2~/cAMP pathways were involved in this process through experiments using inhibitors of eNOS (L-NMMA) and sGC (ODQ) for the first pathway and COX (indomethacin) for the second one. The vasodilator effect of procyanidins was eliminated by the removal of the endothelium. Additionally, inhibition of COX produced a 50% decrease in the vasodilatory activity of these compounds, suggesting the involvement of the PGI~2~/cAMP pathway in their mechanism of action. Subsequent experiments confirmed this finding by observing an increase in PGI~2~ release, which was dependent on the concentration of procyanidins \[[@B201-molecules-18-05814]\].

Other studies have suggested that some natural compounds produce a vasodilator effect by directly activating AC or increasing cAMP levels in smooth muscle cells. The experimental protocols of these studies aimed to evaluate the effects of both an AC inhibitor (SQ22536) and an inhibitor of cAMP-dependent protein kinase (PKA) (KT5720) on the vasodilation produced by the test compound \[[@B79-molecules-18-05814]\]. Additionally, analogs and antagonists of cyclic nucleotides have been used in the evaluation of these pathways \[[@B251-molecules-18-05814]\]. For example, puerarin, an isoflavone isolated from *Radix puerariae* that was evaluated using porcine coronary artery rings, was able to shift the dose-response curve of sodium nitroprusside (SNP) to the left. This effect was independent of the endothelium. The SNP-induced relaxation was enhanced by the cAMP analog, 8-Br-cAMP, at a rate similar to that of puerarin, suggesting the involvement of the PGI~2~/cAMP pathway in the increased vasodilatory activity. Moreover, the cAMP antagonist Rp-8-Br-cAMP decreased the vasoactive effect of this isoflavone. In this case, analogs of cGMP (agonists or antagonists) had no effect on the activity of puerarin. Based on these results, it was suggested that the mechanism of action whereby this isoflavone increases vasodilation in the porcine coronary artery is the activation of the PGI~2~/cAMP pathway \[[@B251-molecules-18-05814]\].

8. Compounds that Inhibit Phosphodiesterases (PDEs)
===================================================

Cyclic nucleotide phospodiesterases (PDEs) are enzymes that regulate the cellular levels of cAMP and cGMP by controlling their rates of degradation \[[@B252-molecules-18-05814]\]. The major PDEs in arterial smooth muscle are PDE1, PDE3, PDE4 and PDE5; specifically, PDE5 has been found to be a major cGMP-hydrolizing PDE expressed in smooth muscle cells. The inhibition of PDEs produces vasorelaxant effects by increasing cyclic nucleotide levels \[[@B252-molecules-18-05814],[@B253-molecules-18-05814],[@B254-molecules-18-05814]\].

Several compounds, mostly flavonoids, have been described as PDE inhibitors and vasodilators \[[@B18-molecules-18-05814],[@B23-molecules-18-05814],[@B29-molecules-18-05814],[@B157-molecules-18-05814]\]. The involvement of PDEs in the vasorelaxant effect of these compounds was evaluated by measuring the change on PDE activity. PDEs have been isolated from the cytosolic fraction of bovine aortic smooth muscle \[[@B18-molecules-18-05814],[@B23-molecules-18-05814]\] or rat aorta \[[@B87-molecules-18-05814]\] and their activities were measured by radioenzimatic assays \[[@B255-molecules-18-05814]\].

Specific PDEs were inhibited by different compounds. For example, the vasorelaxant effect of dioclein inhibited PDE1, and to a lesser extent PDE4 and PDE5 \[[@B23-molecules-18-05814]\]; meanwhile, epigallocatechin-3-gallate showed activity over PDE1 and PDE2 \[[@B29-molecules-18-05814]\], while butein, a chalcone obtained from *Dalbergia odorifera*, inhibited PDE4 only \[[@B87-molecules-18-05814]\].

9. Compounds that Activate K+ Channels
======================================

The K^+^ channels in vascular smooth muscle play an important role in vasodilation because the outflow of K^+^ through these channels hyperpolarizes the membrane and thereby inhibits the entry of Ca^2+^. This process eventually results in the relaxation of blood vessels \[[@B256-molecules-18-05814]\]. Four different types of potassium channels have been characterized in arterial smooth muscle: voltage-dependent channels (K~V~), Ca^2+^-activated channels (large-conductance, BK~Ca~; intermediate-conductance, IK~Ca~; and small-conductance, SK~Ca~), ATP-dependent channels (K~ATP~) and inwardly rectifying channels (K~IR~) \[[@B257-molecules-18-05814],[@B258-molecules-18-05814],[@B259-molecules-18-05814],[@B260-molecules-18-05814]\]. It is worth mentioning that there is evidence for cell to cell, segment to segment, and vascular bed to bed diversity of K^+^ channels that could explain the varying responses of arterial segments or different arteries to stimuli such as hypoxia, vasoactive drugs, or arterial wall injury \[[@B261-molecules-18-05814],[@B262-molecules-18-05814],[@B263-molecules-18-05814]\].

The involvement of different types of K^+^ channels has been evaluated by the use of channel-specific blockers. The following are the most commonly used blockers of K^+^ channels: chloride tetraethylammonium (TEA) and BaCl~2~ as nonselective inhibitors \[[@B22-molecules-18-05814],[@B86-molecules-18-05814]\]; glibenclamide, an inhibitor of K~ATP~ channels; aminopyridine (4-AP), which blocks K~V~ channels; and iberiotoxin \[[@B35-molecules-18-05814]\] and charybdotoxin, which block BK~Ca~ channels \[[@B42-molecules-18-05814],[@B98-molecules-18-05814]\]. In addition, TEA \[[@B82-molecules-18-05814]\], BaCl~2~ \[[@B22-molecules-18-05814]\], and apamin \[[@B31-molecules-18-05814]\] have been used to block BK~Ca~, K~IR~, and SK~Ca~ channels, respectively.

BK~Ca~, highly expressed in vascular smooth muscle cells \[[@B258-molecules-18-05814]\], can be activated by both, the NO/cGMP pathway \[[@B264-molecules-18-05814]\] and EDHF \[[@B265-molecules-18-05814]\]. These channels play a key role in blood pressure regulation and therefore, they have been suggested as novel potential drug targets for the treatment of cardiovascular diseases \[[@B266-molecules-18-05814]\]. Recently, a considerable number of natural compounds, especially of the flavonoid type, have been shown to have a vasodilator effect caused, at least in part, by activation of BK~Ca~ channels \[[@B19-molecules-18-05814],[@B22-molecules-18-05814],[@B198-molecules-18-05814],[@B267-molecules-18-05814],[@B268-molecules-18-05814]\]. Other compounds with different chemical structures that activate this kind of potassium channels are: diosgenin (steroid sapogenin) \[[@B62-molecules-18-05814]\]; piceatannol (stilbene) \[[@B32-molecules-18-05814]\], isolated from the root of *Rheum undulatum*; and rotundifolone (monoterpene) \[[@B42-molecules-18-05814]\], the major constituent of the essential oil of *Mentha x villosa* Hudson.

The study of compounds that activate K^+^ channels also includes the use of electrophysiological techniques, both to demonstrate these compounds' role as stimulants and to characterize the type of channels involved in their vasodilator mechanisms. The most common strategy is the patch-clamp technique used on isolated muscle cells \[[@B116-molecules-18-05814]\] or in *Xenopus* oocytes that express K^+^ channels from other organisms \[[@B269-molecules-18-05814]\]. For example, the elucidation of the mechanism of action of rotundifolone was carried out in rat superior mesenteric arteries. For investigating the involvement of K^+^ channels in the vasorelaxant mechanism, several specific channel blockers were used such as TEA, charybdotoxin, 4-AP and glibenclamide. In addition, electrophysiological testing using the patch-clamp technique in mesenteric smooth muscle cells was used to identify the channels activated by rotundifolone. The results indicated that the vasodilator effect of this compound involves the participation of BK~Ca~ channels \[[@B42-molecules-18-05814]\]. However, it has been shown that the use of the patch-clamp technique induces apparent phenotypic changes, particularly when it is used on isolated and cultured cells, compared to data derived from intact tissue. Consequently, data gathered in this manner should be interpreted with caution \[[@B270-molecules-18-05814]\].

10. Compounds that Decrease Intracellular Ca^2+^ Concentration
==============================================================

The mechanism of vascular smooth muscle contraction involves the participation of different signal transduction pathways, all of which converge to increase cytoplasmic Ca^2+^ concentrations. The concentration of this cation increases both by extracellular Ca^2+^ entering through voltage-operated Ca^2+^ channels (VOCCs) and receptor-operated Ca^2+^ channels (ROCCs), and by the release of Ca^2+^ from intracellular stores \[[@B123-molecules-18-05814]\]. Therefore, the mechanisms of action associated with vasodilating agents that decrease intracellular Ca^2+^ concentration involve blocking VOCCs and ROCCs or inhibiting the release of this cation from intracellular stores. The experimental strategy to determine the involvement of Ca^2+^ channels in the vasodilating effect of test compounds involves incubating aortic rings in a Ca^2+^-free medium containing a high concentration of K^+^ and to which CaCl~2~ is gradually added to induce contraction, both in the absence and presence of the vasodilating compound \[[@B79-molecules-18-05814],[@B123-molecules-18-05814]\].

Different techniques are used to determine the involvement of VOCCs, ROCCs or the release of intracellular calcium. The inhibitory action of vasodilator compounds on VOCCs can be seen as a rightward shift in the dose-response curve for CaCl~2~, as noted in the case of ligustilide, a compound extracted from *Ligusticum chuanxiong*, a plant used in traditional Chinese medicine \[[@B179-molecules-18-05814]\], and naucline, an alkaloid derived from *Nauclea officinalis* \[[@B89-molecules-18-05814]\]. For evaluating the involvement of ROCCs, dose-response curves are performed in the presence of an adrenergic agonist, such as noradrenaline (NA) \[[@B123-molecules-18-05814]\] or phenylephrine (PE) \[[@B56-molecules-18-05814]\] to induce contractions, both in the absence and the presence of the vasodilator compound \[[@B89-molecules-18-05814],[@B123-molecules-18-05814]\]. In addition, the contribution of Ca^2+^ released from intracellular stores is determined by incubating the tissue in a Krebs solution free of Ca^2+^ and to which NA is subsequently added to induce phasic contractions with calcium from the sarcoplasmic reticulum. Subsequently, once the contraction is stabilized, CaCl~2~ is added to induce a tonic contraction. When incubating segments of the aorta with the test compound under these conditions, a decrease of phasic contractions signals that the effect is produced by the outflow of intracellular Ca^2+^, whereas a decrease in tonic contraction signals that the effect is mediated by Ca^2+^ entry through ROCCs \[[@B185-molecules-18-05814]\].

The release of Ca^2+^ from intracellular stores is regulated by the inositol-1,4,5-triphosphate (IP~3~) system and by the ryanodine receptors (RyRs). RyRs system are a Ca^2+^ release system where Ca^2+^ release is induced by the presence of Ca^2+^ when the receptors are activated by caffeine \[[@B179-molecules-18-05814]\]. For example, isopropyl-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate has been shown to inhibit both KCl-induced and norepinephrine-induced contractions in the absence and presence of Ca^2+^ in the rat mesenteric artery. These results suggest that in addition to its activity on VOCCs, this compound also acts on ROCCs and on intracellular calcium stores \[[@B123-molecules-18-05814]\]. In this type of study, blockers of L-type Ca^2+^ channels, such as nifedipine \[[@B271-molecules-18-05814]\] or diltiazem \[[@B154-molecules-18-05814]\], are used as a positive control. However, calycosin, the main component of *Astragali radix*, was shown to inhibit CaCl~2~-induced vasoconstriction in the presence of KCl and PE but did not affect PE-induced contractions in a calcium-free medium. These results indicated the involvement of VOCCs and ROCCs in the vasodilator effect produced by calicosin, excluding the outflow of intracellular Ca^2+^ \[[@B93-molecules-18-05814]\]. In contrast, low concentrations of euxanthone, a metabolite isolated from *Polygala caudate*, inhibited the phasic contraction, suggesting that the exit of Ca^2+^ from the endoplasmic reticulum is involved in the relaxing activity \[[@B139-molecules-18-05814]\]. Moreover, both cardamonin and alpinetin can inhibit the transient contractions produced by PE and caffeine in a Ca^2+^-free medium and also the contractions induced by K^+^. The authors suggest that these compounds act through the nonspecific inhibition of Ca^2+^ entry and the release of intracellular Ca^2+^ \[[@B69-molecules-18-05814]\].

Other methodologies have been used to elucidate the mechanisms of action of vasoactive compounds. For example, the involvement of VOCCs in the vasodilator mechanism of marrubenol, a diterpene extracted from *Marrubium vulgare*, was confirmed by recording the inflow current through calcium channels using patch-clamp and fluorescence techniques \[[@B183-molecules-18-05814]\].

11. Compounds that Activate Endothelial Transient Receptor Potential (TRP) Cation Channels
==========================================================================================

Transient receptor potential (TRP) cation channels are currently considered as the leading candidate proteins mediating diverse non-voltage-gated calcium entry pathways in vascular endothelium and smooth muscle \[[@B272-molecules-18-05814],[@B273-molecules-18-05814]\]. The TRP superfamily contains three major subfamilies based on sequence homology: TRPV (vanilloid), TRPC (canonical), and TRPM (melastatin). Moreover, three additional subfamilies (the "distant TRPs"), TRPP (polycystin), TRPML (mucolipin), and TRPA (ankyrin) have been proposed \[[@B274-molecules-18-05814]\]. In particular, the endothelial TRP channels are exposed to different agonists that enter the blood stream as dietary molecules. Some of these molecules, found in commonly consumed food and plants used in traditional medical practices of several cultures are able to activate these kinds of channels \[[@B97-molecules-18-05814],[@B272-molecules-18-05814],[@B273-molecules-18-05814]\]. Carvacrol, one of the major components of oregano (*Origanum vulgare*) essential oil, induces an endothelium-dependent vasodilation by activating TRPV3 \[[@B97-molecules-18-05814]\]. Recently, it has been reported that allyl isothiocyanate, which is found in the seeds of mustard (*Brassica nigra* and *B. juncea*) causes endothelium-dependent vasodilation of rat cerebral arteries by a mechanism involving TRPA1 activation \[[@B66-molecules-18-05814]\].

12. Compounds that Inhibit Protein Kinase C
===========================================

The mechanism of vascular smooth muscle contraction evokes the phosphorylation of myosin light chain by increasing intracellular Ca^2+^ concentration. Additionally, the decrease of the myosin light chain phosphatase (MLCP) increases the sensitivity to Ca^2+^ \[[@B275-molecules-18-05814]\]. Several pathways have been suggested for the Ca^2+^ sensing mechanism. One of them is the PKC/CPI-17 pathway \[[@B276-molecules-18-05814]\]. PKC phosporilates CPI-17, enhancing its inhibitory activity over MLCP \[[@B276-molecules-18-05814]\] and producing a sustained contraction. PKC has been found in high concentrations in vascular smooth muscle and can be activated by diacylglicerol \[[@B277-molecules-18-05814]\].

Only a few compounds have been found to evoke their vasorelaxant activity through this mechanism; in all cases, PKC inhibition was not the only mechanism. The participation of PKC in the vasorelaxant mechanism has been evaluated using activators of PKC in smooth muscle cells, such as phorbol esters. 12-*O*-tetradecanoyl phorbol 13-acetate, phorbol 12-myristate-13-acetate (PMA) and phorbol 12,13-dibutyrate (PDB) were used to evaluate the vasorelaxant mechanisms for dioclein \[[@B21-molecules-18-05814]\], quercetin \[[@B24-molecules-18-05814]\] and euxanthone \[[@B139-molecules-18-05814]\], respectively. This last activator was used also in the characterization of the mechanism of action for thymol and carvacrol: PDB induced a sustained contraction that was attenuated when thymol or carvacrol were added (300 and 1,000 µM) \[[@B96-molecules-18-05814]\].

13. Conclusions
===============

The present review focused on the mechanisms of action responsible for the vasodilator activity of plant-derived compounds. From the information obtained, we identified the main mechanisms of action of most of the vasodilator compounds; these mechanisms are the activation of the NO/cGMP and PGI~2~/cAMP pathways, the activation of K^+^ channels and the blockade of voltage-dependent Ca^2+^ channels.

It should be noted that more than one mechanism of action has been proposed to be involved in the vasodilator effect of almost half of all of the analyzed compounds. This finding suggests that compounds derived from plants may have great therapeutic potential as they involve multiple mechanisms of action in their vascular relaxing activity. In this context, it is critical to emphasize the importance of understanding the different mechanisms of action in order to establish new therapeutic strategies for addressing various cardiovascular diseases.

Finally, given the structural diversity of the active compounds derived from natural products and the diversity of mechanisms of action responsible for their vasodilator activity, it is important to continue the search for new active substances that help in the treatment of cardiovascular diseases.
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